Minimal disease activity (MDA) in atopic dermatitis (AD) is a concept that combines a treat-to-target therapeutic strategy with the principle of shared decision-making. The aim is to achieve a state in which AD has minimal impact on the patient’s life by achieving pre-agreed disease control goals through the use of an appropriate systemic therapy. Prof. Dr. med. Schmid-Grendelmeier gave a practice-oriented overview of the MDA concept in his presentation.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Atopic Dermatitis in Children and Adults
Topically Applied “Small Molecules”: Janus Kinases or PDE-4 as Targets?
- Dermatomyositis
Glucocorticoids for more than one year
- The Brain and the Motivation to Eat
Why is it so hard to lose weight?
- Diabetic Polyneuropathy
Clinical Presentation, Diagnosis, and Treatment of DSPN
- From symptom to diagnosis
Pulmonology – Lobus venae acygos
- Atopic Dermatitis: Precisely Targeting Immunological Targets
Interleukin blockade or OX40-(L) inhibition?
- Fibromyalgia Syndrome
Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity
- Across All Types of Cancer